During the past decade, Peripheral Vascular Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peripheral Vascular Associates" #1 sponsor was "Angiotech Pharmaceuticals" with 2 trials, followed by "Healthpoint" with 2 trials sponsored, "AnGes USA, Inc." with 1 trials sponsored, "Anesiva, Inc." with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peripheral Vascular Associates" #1 collaborator was "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Peripheral Vascular Associates" are "Intermittent Claudication" (3 trials), "Peripheral Arterial Disease" (3 trials), "Peripheral Vascular Disease" (3 trials), "Hyperplasia" (2 trials) and "Ischemia" (2 trials). Many other conditions were trialed in "Peripheral Vascular Associates" in a lesser frequency.

Most popular intervention types in "Peripheral Vascular Associates" are "Device" (6 trials), "Biological" (4 trials), "Drug" (3 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ad2/HIF-1α/VP16" (1 trials), "CGT003 (E2F Duplex Decoy)" (1 trials), "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials) and "Disadvantaged Autologous Vein Graft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peripheral Vascular Associates" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Peripheral Vascular Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Peripheral Vascular Associates, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Peripheral Vascular Associates, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".